Core Insights - Eli Lilly and Walmart have partnered to offer single-dose vials of the weight loss drug Zepbound at Walmart pharmacies, matching the price available through LillyDirect [1][2][3] - The service will be available at nearly 4,600 Walmart pharmacies across the U.S. by mid-November, allowing customers to select local pickup during the checkout process on LillyDirect [2][5] - This collaboration marks LillyDirect's first retail partnership and aims to enhance access to prescription medications for patients managing chronic diseases like obesity [3][4][6] Company and Industry Developments - The partnership is designed to provide additional convenience and choice for customers in obtaining their medications, addressing access challenges faced by patients [4][5] - LillyDirect, launched in January 2024, serves as a digital healthcare platform for patients with obesity, migraines, and diabetes, facilitating access to healthcare providers and home delivery of medications [6] - The trend towards consolidated online healthcare platforms is highlighted, indicating a shift in consumer preferences for streamlined healthcare management [7]